SMAD3 and chronic obstructive pulmonary disease: To our knowledge, this is the first study to show that the p-Erk1/2 and the Smad3/PGC-1α signaling pathway are involved in the downregulation of Fndc5/irisin in COPD-related skeletal muscle dysfunction.